Related Experiment Video

Updated: Apr 24, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

7.7K

NOTCH1 downregulation contributes to PI3K inhibitor resistance in T-ALL

    Cancer Discovery
    |September 4, 2014
    PubMed

    Insights

    Inhibition of phosphoinositide 3-kinase (PI3K) in T-cell acute lymphoblastic leukemia (T-ALL) therapy promotes the growth of resistant cancer cells. These resistant cells have lost the NOTCH1 gene, which is crucial for T-ALL development.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Cancer Genetics

    Background:

    • T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood cancer.
    • The phosphoinositide 3-kinase (PI3K) pathway is a key driver in T-ALL pathogenesis.
    • Targeting PI3K is a therapeutic strategy, but resistance mechanisms are not fully understood.

    Purpose of the Study:

    • To investigate the mechanisms of drug resistance in T-ALL following PI3K inhibition.
    • To identify genetic alterations associated with resistance to PI3K-targeted therapies.

    Main Methods:

    • Utilized T-ALL cell lines and patient-derived xenografts.
    • Employed genetic sequencing and functional assays to analyze resistant clones.
    • Assessed the role of NOTCH1 in PI3K inhibitor sensitivity.

    Main Results:

    • PI3K inhibition in T-ALL selects for clones with acquired resistance.
    • Loss of oncogenic NOTCH1 was identified as a common resistance mechanism.
    • NOTCH1-deficient T-ALL cells exhibited reduced sensitivity to PI3K inhibitors.

    Conclusions:

    • Loss of NOTCH1 is a critical mechanism of acquired resistance to PI3K inhibition in T-ALL.
    • Understanding this resistance pathway is essential for developing more effective T-ALL treatments.
    • Future therapies may need to consider targeting NOTCH1 or its downstream effects in combination with PI3K inhibitors.

    More Related Videos

    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

    Published on: January 12, 2020

    6.3K
    Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

    Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

    Published on: July 17, 2020

    5.7K

    Related Concept Videos

    Notch Signaling Pathway03:14

    Notch Signaling Pathway

    The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
    The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
    4.6K
    Notch Signaling Pathway03:14

    Notch Signaling Pathway

    4.9K
    Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

    Role Of Notch Signalling In Intestinal Stem Cell Renewal

    Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
    Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
    1.8K
    The JAK-STAT Signaling Pathway01:20

    The JAK-STAT Signaling Pathway

    Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
    10.1K
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    5.1K
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
    2.0K